Synthesis method of dapagliflozin

A production method and compound technology, applied in the field of dapagliflozin synthesis, can solve the problems of high cost, strong hygroscopicity of zinc bromide, unfavorable amplification and operation, etc.

Inactive Publication Date: 2015-04-08
HYBIO PHARMA
View PDF7 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Dapagliflozin is also reported in other documents, for example, adopting zinc reagent and 2,3,4,6,-tetrapivaloyl-α-D-glucopyranose bromide reaction can obtain Dapagliflozin (Org .Lett.,Vol.14,No.6,2012), however, the hygroscopicity of zinc bromide in this method is particularly strong, which is not conducive to scale-up and operation
And in the report of this document, the experimental scale is small, which is at the level of experimental research, which has great limitations, and the 2,3,4,6,-tetrapivaloyl-α-D-glucopyranose bromide used More expensive and lower yield than 2,3,4,6,-tetraacetoxy-α-D-glucopyranose bromide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of dapagliflozin
  • Synthesis method of dapagliflozin
  • Synthesis method of dapagliflozin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: the preparation of compound 1

[0034]

[0035] Under the condition of argon protection, add 300mL of dried tetrahydrofuran (THF) and 65.5g (200mmol) of 5-bromo-2-chloro-4-ethoxydiphenylmethane into a 1L three-necked flask. Bath to control the temperature of the reaction system at -78°C, slowly add n-butyl lithium (n-BuLi) 80mL (2.5mol / L, 200mmol, 1eq) dropwise, control the temperature of the reaction system below -78°C , after the dropwise addition, continue to keep at -78°C for 1 hour;

[0036] Then slowly add 19.1g (100mmol) of cuprous iodide to the reaction system, control the temperature of the reaction system at -40~-30°C for 1 hour, then slowly add 2,3,4, 6-tetra-O-acetyl-α-D-glucopyranose THF solution (41.5g, 100mmol, THF 100mL, 0.5eq), control the reaction temperature at -40~-30°C during the addition process and keep the temperature React for 1 hour, and slowly return the temperature of the reaction system to room temperature and react for 3 ...

Embodiment 2

[0040] Embodiment 2: the preparation of compound 1

[0041]

[0042] Under the condition of argon protection, 350mL of dried THF and 163.1g (500mmol) of 5-bromo-2-chloro-4-ethoxydiphenylmethane were added to a 1L three-necked flask, and the reaction was decomposed with acetone / dry ice bath. The temperature of the system is controlled at -60°C, and 240mL (2.5mol / L, 600mmol, 1.2eq) of n-butyllithium is slowly added dropwise. During the dropping process, the temperature of the reaction system is controlled below -60°C. React at -60°C for 1 hour;

[0043] Then slowly add 24.2g (240mmol) of cuprous iodide to the reaction system, control the temperature of the reaction system at -30~-20°C for 1 hour, then slowly add 2,3,4, 6-tetra-O-acetyl-α-D-glucopyranose in THF solution (98.8g, 240mmol, THF 150mL, 1.0eq), control the reaction temperature at -30~-20°C during the addition process and keep the temperature React for 1 hour, slowly return the temperature of the reaction system to...

Embodiment 3

[0047] Embodiment 3: the preparation of compound 1

[0048]

[0049] Under the condition of argon protection, 800mL of dried THF and 99.2g (266mmol) of 5-iodo-2-chloro-4-ethoxydiphenylmethane were added to a 2L three-necked flask, and the reaction was carried out in an acetone / dry ice bath. The temperature of the system is controlled at -50°C, and 160mL (2.5mol / L, 400mmol, 1.5eq) of n-butyllithium is slowly added dropwise. During the dropping process, the temperature of the reaction system is controlled at -50°C. React at 50°C for 1 hour;

[0050] Then slowly add 49.1g (100mmol) of magnesium bromide to the reaction system, control the temperature of the reaction system at -20~-10°C for 1 hour, then slowly add 2,3,4,6 -Tetra-O-acetyl-α-D-glucopyranose THF solution (98.5g, 240mmol, THF 200mL, 0.9eq), control the reaction temperature at -10~0°C during the addition process and keep the temperature for reaction 1 hour, slowly return the temperature of the reaction system to ro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synthesis method of dapagliflozin. The halogeno-benzene derivative and 2,3,4,6-tetraacetyloxy-alpha-D-glucopyranose bromide are used as the raw materials, thereby saving the reduction reaction and acetylation reaction in the original method, shortening the reaction processing steps and enhancing the total yield. The phenyl lithium reagent is prepared into the copper lithium reagent or Grignard reagent intermediate with mild reaction conditions to reduce the generation of the byproduct, so that the reaction temperature is controlled at -10 DEG C below.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a method for synthesizing dapagliflozin. Background technique [0002] Dapagliflozin (generic name: Dapagliflozin) is a type 2 diabetes drug developed by Bristol-Myers Squibb and AstraZeneca. The drug trade name: Farxiga (US), Forxiga (EU). Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Its molecular structural formula is as follows: [0003] [0004] The synthetic method of dapagliflozin: the synthesis dapagliflozin reported in the existing patent (US20040138439) adopts TMS-protected gluconolactone and halogenated benzene derivatives as raw materials. The derivatives of halogenated benzene are prepared into active phenyllithium reagents to react with gluconolactone, and the obtained intermediate reaction solution is directly qu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D309/10
CPCC07D309/10
Inventor 陈新亮姚志军李国弢刘建马亚平袁建成
Owner HYBIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap